Dr Sheridan Wilson was elected to the BCT Board of Directors in July 2022. She is a Medical Oncologist at Auckland City Hospital in New Zealand. Sheridan is clinical lead for the medical oncology team providing systemic treatment across the Auckland region and in 2018...
Associate Professor Nicholas Wilcken was elected to the Breast Cancer Trials Board of Director in July 2016 and is a member of the Scientific Advisory Committee. He was the Chair of the BCT’s Scientific Advisory Committee from 2011 to March 2017. Associate Professor...
Professor Andrew Spillane was elected to the BCT Board in July 2021 and is a member of the Finance, Risk and Audit Committee. He is a Professor of Surgical Oncology at The University of Sydney. He specialises in the surgical management of breast cancer and melanoma....
Professor Christobel Saunders AO was elected to the BCT Board of Directors in July 2016. Professor Saunders AO, MB BS, FRCS, FRACS, FAAHMS is the James Stewart Chair of Surgery, the Head of the Department of Surgery at the University of Melbourne (Royal Melbourne...
Ms Marg O’Donnell AO was appointed to the BCT Board of Directors in August 2017 and stepped down from the Board in July 2022. She works as a consultant, Mentor and Board Director. She has chaired a range of NFP, University and Government boards, including: SANE...
